Cence Consulting is a strategic medico-marketing consultancy which focuses on assessing the commercial potential of new opportunities. We have many years’ first-hand experience working with emerging pharmaceutical and biotechnology products, from disease area strategies, portfolio decision making, early brand management to licensing evaluations. Whether the opportunity relates to products from in-house R&D, licensing candidates or new options for existing products, we can identify and explore commercial opportunities, forecast the market potential and develop appropriate commercial strategies.

We specialise in early stage products – from discovery to end of Phase II – but of course this does not exclude life-cycle management plans or the identification of new avenues for established brands.
Our team of commercial strategists, business analysts and medical affairs experts have the breadth and depth of experience to undertake complete commercial evaluations or provide tailored support to in-house marketing strategy or business development teams.

We also run workshops: we do not deliver off-the-peg courses (we’ve all been on generic courses that weren’t quite what we needed) and would rather work with you to design a workshop that precisely meets your organisation’s needs.